Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bryan Heart, formerly known as the BryanLGH Heart Institute, is a premier cardiovascular care provider and clinical research center based in Lincoln, Nebraska. Operating as a specialized division of the non-profit Bryan Health system, the institute provides a comprehensive range of services including interventional cardiology, cardiothoracic surgery, vascular surgery, and electrophysiology. Bryan Heart is a prominent partner in national clinical research, hosting Phase II and Phase III trials for innovative pharmaceuticals and medical devices. The institute is recognized for its clinical excellence, having earned the HeartCARE Center National Distinction of Excellence from the American College of Cardiology. Through its extensive network of outreach clinics, Bryan Heart serves patients across Nebraska and the surrounding multi-state region with advanced diagnostic and therapeutic options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BryanLGH Heart Institute.